Market Research Reports

Published Reports

log AIDS Related Primary CNS Lymphoma Treatment Market by Product Type, Application and Region - Global Market Analysis and Forecast (2019 - 2029)

Published on - September, 2022 | Report Code - HC2022920RD | Pages - 95

The global aids related primary cns lymphoma treatment market outlook study is a comprehensive databook that provides key market data on the global aids related primary cns lymphoma treatment industry. Some of the prominent players in the market are AbbVie, Amgen, Bristol-Myers Squibb, Cipla, Dr. Reddys Laboratories, Fresenius SE & Co. KGaA, Gilead Science, Merck, Novartis, Roche, Sanofi S.A.. The research report on the global aids related primary cns lymphoma treatment market provides extensive competition analysis and competitive conditions. The report includes information on significan...

log Central Nervous System (CNS) Lymphoma Treatment Market by Product Type, Application and Region - Global Market Analysis and Forecast (2019 - 2029)

Published on - September, 2022 | Report Code - HC2022920RC | Pages - 90

The global central nervous system (cns) lymphoma treatment market outlook study is a comprehensive databook that provides key market data on the global central nervous system (cns) lymphoma treatment industry. Some of the prominent players in the market are AbbVie, Amgen, Bristol-Myers Squibb, Cipla, Dr. Reddys Laboratories, Fresenius SE & Co. KGaA, Gilead Science, Merck, Novartis, Roche, Sanofi S.A.. The research report on the global central nervous system (cns) lymphoma treatment market provides extensive competition analysis and competitive conditions. The report includes information o...

log B-Cell Non-Hodgkins Lymphoma (NHL) Treatment Market by Product Type, Application and Region - Global Market Analysis and Forecast (2019 - 2029)

Published on - September, 2022 | Report Code - HC2022920RB | Pages - 97

The global b-cell non-hodgkins lymphoma (nhl) treatment market outlook study is a comprehensive databook that provides key market data on the global b-cell non-hodgkins lymphoma (nhl) treatment industry. Some of the prominent players in the market are AbbVie, Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Merck Serono, Novartis, Roche. The research report on the global b-cell non-hodgkins lymphoma (nhl) treatment market provides extensive competition analysis and competitive conditions. The report includes information on significant products, players, challenges and developments, and other ...

log Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market by Product Type, Application and Region - Global Market Analysis and Forecast (2019 - 2029)

Published on - September, 2022 | Report Code - HC2022920QZ | Pages - 95

The global angioimmunoblastic t-cell lymphoma (ailt) treatment market outlook study is a comprehensive databook that provides key market data on the global angioimmunoblastic t-cell lymphoma (ailt) treatment industry. Some of the prominent players in the market are Bristol-Myers Squibb, Cellerant Therapeutics, Eisai Co., Ltd., Genmab AS, Merck, Novartis, Roche, Seattle Genetics, Takeda Pharmaceutical. The research report on the global angioimmunoblastic t-cell lymphoma (ailt) treatment market provides extensive competition analysis and competitive conditions. The report includes information o...

log Cutaneous Cell Lymphoma Treatment Market by Product Type, Application and Region - Global Market Analysis and Forecast (2019 - 2029)

Published on - September, 2022 | Report Code - HC2022920QY | Pages - 97

The global cutaneous cell lymphoma treatment market outlook study is a comprehensive databook that provides key market data on the global cutaneous cell lymphoma treatment industry. Some of the prominent players in the market are Amgen, AstraZeneca, Bristol-Myers Squibb, Epizyme, Genmab AS, Gilead Sciences, Johnson & Johnson, Medivir AB, Merck, NanoString Technologies, Novartis, Pfizer, Roche, Seattle Genetics, Soligenix. The research report on the global cutaneous cell lymphoma treatment market provides extensive competition analysis and competitive conditions. The report includes inform...

log Lymphoma Treatment Market by Product Type, Application and Region - Global Market Analysis and Forecast (2019 - 2029)

Published on - September, 2022 | Report Code - HC2022920QX | Pages - 101

The global lymphoma treatment market outlook study is a comprehensive databook that provides key market data on the global lymphoma treatment industry. Some of the prominent players in the market are Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GSK, Genmab AS, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Seattle Genetics, Takeda Pharmaceutical. The research report on the global lymphoma treatment market provides extensive competition analysis and competitive conditions. The report includes information on significant products, players, challenges and developments, and other ...

log Marginal Zone Lymphoma Treatment Market by Product Type, Application and Region - Global Market Analysis and Forecast (2019 - 2029)

Published on - September, 2022 | Report Code - HC2022920QW | Pages - 92

The global marginal zone lymphoma treatment market outlook study is a comprehensive databook that provides key market data on the global marginal zone lymphoma treatment industry. Some of the prominent players in the market are AbbVie, Astellas Pharma, Bristol-Myers Squibb, GSK, Genmab AS, Incyte Corporation, Johnson & Johnson, Merck, Novartis, Roche, TG Therapeutics. The research report on the global marginal zone lymphoma treatment market provides extensive competition analysis and competitive conditions. The report includes information on significant products, players, challenges and d...

log Cutaneous T-Cell Lymphoma (CTCL) Treatment Market by Product Type, Application and Region - Global Market Analysis and Forecast (2019 - 2029)

Published on - September, 2022 | Report Code - HC2022920QV | Pages - 100

The global cutaneous t-cell lymphoma (ctcl) treatment market outlook study is a comprehensive databook that provides key market data on the global cutaneous t-cell lymphoma (ctcl) treatment industry. Some of the prominent players in the market are AstraZeneca, Bristol-Myers Squibb, Genmab AS, Medivir AB, Merck, Novartis, Pfizer, Roche, Seattle Genetics, Soligenix. The research report on the global cutaneous t-cell lymphoma (ctcl) treatment market provides extensive competition analysis and competitive conditions. The report includes information on significant products, players, challenges and...

log Peripheral T-Cell Lymphoma (PTCL) Treatment Market by Product Type, Application and Region - Global Market Analysis and Forecast (2019 - 2029)

Published on - September, 2022 | Report Code - HC2022920QU | Pages - 91

The global peripheral t-cell lymphoma (ptcl) treatment market outlook study is a comprehensive databook that provides key market data on the global peripheral t-cell lymphoma (ptcl) treatment industry. Some of the prominent players in the market are Bristol-Myers Squibb, Genmab AS, Leadiant Biosciences, Merck, Pacira Pharmaceuticals (Skyepharma), Pfizer, Spectrum Pharmaceuticals. The research report on the global peripheral t-cell lymphoma (ptcl) treatment market provides extensive competition analysis and competitive conditions. The report includes information on significant products, player...

log T-Cell Lymphoma Treatment Market by Product Type, Application and Region - Global Market Analysis and Forecast (2019 - 2029)

Published on - September, 2022 | Report Code - HC2022920QT | Pages - 86

The global t-cell lymphoma treatment market outlook study is a comprehensive databook that provides key market data on the global t-cell lymphoma treatment industry. Some of the prominent players in the market are Amgen, BioCryst Pharmaceuticals, Bristol-Myers Squibb, Eisai Co., Ltd., Genmab AS, Johnson & Johnson, Medivir AB, Merck, Novartis, Seattle Genetics, Shenzhen ChipScreen Biosciences, Ltd., Shionogi, Sorrento Therapeutics, Spectrum Pharmaceuticals. The research report on the global t-cell lymphoma treatment market provides extensive competition analysis and competitive conditions....